Improving efficacy of antifungal therapy by polymerase chain reaction-based strategy among febrile patients with neutropenia and cancer

Clinical Infectious Diseases

Volumn 33, Issue 10, 2001, Pages 1621-1627

  Lin, Ming Tsan ^b   Lu, Hsi Chi ^a   Chen, Woan Ling ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; FLUCONAZOLE;

ADOLESCENT; ARTICLE; BLOOD CULTURE; CANCER PATIENT; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; EARLY DIAGNOSIS; FEBRILE NEUTROPENIA; HUMAN; INFANT; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MYCOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT PLANNING;

ADOLESCENT; ANTIFUNGAL AGENTS; BLOOD; CULTURE MEDIA; DNA, FUNGAL; FEVER; FUNGEMIA; FUNGI; HUMANS; MYCOSES; NEOPLASMS; NEUTROPENIA; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 18S; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0035889460     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322631     Document Type: Article

References (30)

1. Fungal infections in cancer patients: An international autopsy survey
2. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
3. Fungal blood cultures
4. Hepatosplenic yeast infection in patients with acute leukemia: A diagnostic problem
5. Empiric antifungal therapy in febrile granulocytopenic patients
6. Empiric treatment of fungal infections in the neutropenic host: Review of the literature and guidelines for use
7. Empiric therapy with amphotericin B in febrile granulocytopenic patients
8. Emerging fungal pathogens, drug resistance and the role of lipid formulations of amphotericin B in the treatment of fungal infections in cancer patients: A review
9. Meta-analysis of prophylactic or empiric antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia
10. Amphotericin B: 30 years of clinical experience
11. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
12. Lipisomal amphotericin B for empiric therapy in patients with persistent fever and neutropenia
13. Application of the polymerase chain reaction to the diagnosis of candidiasis by amplification of an HSP 90 gene fragment
14. Detection of a wide range of medically important fungi by the polymerase chain reaction
15. Rapid identification of Candida species in blood culture by a clinically useful PCR method
16. PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis
17. Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis
18. Detection and identification of fungal pathogens in blood by using molecular probes
19. The epidemiology of candidemia in two United States cities: Result of a population-based active surveillance
20. PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies
21. Hepatosplenic candidiasis, a late manifestation of Candida septicemia in neutropenic patients with haematologic malignancies
22. Hepatosplenic candidiasis - A late manifestation of Candida septicemia
23. Fungal infections in bone marrow transplant patients
24. Invasive fungal disease in adults undergoing remission induction chemotherapy for acute myeloid leukemia: The pathogenic role of the antileukemic regimen
25. Filgrastim (r-meHuG-CSF): The first 10 years
26. Evaluation of PCR for detection of DNA specific for Aspergillus species in sera of patients with various forms of pulmonary aspergillosis
27. Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis
28. Specific detection of Aspergillus species in blood and bronchoalveolar samples of immunocompromised patients by two-step PCR
29. Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction
30. Avoiding false-positives with PCR